DISTRIBUTION

Now in its 17th year, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry Gurus’ to discuss and encourage debate on some of the more challenging issues surrounding the technological, strategic and business facets of the
pharma and biopharmaceutical industry. DDW has always adhered to the maxim... ‘Turning science into business’.

DDW examines the advances in new science and technology with a view to the commercial implications of implementing those advances and whether they can truly bring benefits to the industry as a whole and, more importantly, the discovery and development of new therapeutics.

DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level allowing them to understand the new technologies and the impact they can have on their particular segments of the business. Scientist and CEO alike can profit from the uncomplicated style of the editorial and, furthermore, gain a wealth of information on a diverse range of life science topics. In our articles, we challenge the industry to look at new ways of overcoming discovery bottlenecks, embrace new technologies and build next generation technology platforms.

Distriubtion

Types of Reader: A blend of bench level Chemists, Biologists and Investigators moving through to Departmental Heads and Senior Management.

From Bench to Boardroom DDW will guarantee your message is seen. We are also offering an online version with video links within your advertisement, a great opportunity for product management to outline the benefits of your companies’ products and technology.

Email lists are also available to rent as well as online Banner, MPU and Tower adverts to complement your print campaign. With 3,500 Unique Visitors a month, DDW can offer great click through and open rate statistics.

distribution 2
JOB FUNCTION TOTAL QUALIFIEDPERCENTAGE OF TOTAL
 
CEO/President/Owner2,18914%
 
Director of Research
VP Research
Lab Director/Lab Manager/Dept Manager
VP Drug Development
4,39628%
 
Group or Section Leader
Project Manager
Professor/Instructor
Academic Dept/Chair
3,217 21%
 
Principal Investigator
Research Scientist
2,954 19%
 
Consultant
Process Engineer
Purchasing Manager/Agent
1,089 7%
 
Other 1,782 11%
 

INDUSTRY TOTAL QUALIFIED PERCENTAGE OF TOTAL
 
Pharma
Biotech
Biopharma
CRO
Independent Lab
11,567 76%
 
Academic
Government
Clinical/Medical
Consulting
3,622 24%
 
WHAT OUR READERS SAY | DISTRIBUTION | 2017 EDITORIAL FOCUS | RATES & SPECS